Trials / Completed
CompletedNCT07078396
Duration and Quality of 1% Ropivacaine Ankle Blocks
Duration and Analgesic Quality of 1% Ropivacaine Ankle Blocks for Forefoot Surgeries - A Retrospective Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 56 (actual)
- Sponsor
- Ziekenhuis Oost-Limburg · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to determine the analgesic duration and analgesic quality of a 1% ropivacaine ankle block in forefoot surgery. Bilateral cases of forefoot surgery, preoperative use of steroids, preexisting lower extremity neuropathy, or failed blocks were not included in this quality improvement program. An ankle block with 1% ropivcaine and patient follow-up is part of the standard practice at Ziekenhuis Oost-Limburg.
Conditions
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2024-04-24
- Completion
- 2024-04-30
- First posted
- 2025-07-22
- Last updated
- 2025-07-22
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT07078396. Inclusion in this directory is not an endorsement.